Jubilant Pharma Holdings Inc. enters into loan agreement with Standard Chartered Bank
To benefit from a loan facility to repay existing debts and finance capital expenditure
Jubilant Pharmova’s wholly-owned subsidiary, Jubilant Pharma, today announced that its subsidiary Jubilant Pharma Holdings Inc. (JPHI) has entered into an agreement with Standard Chartered Bank for a five-year loan facility for the repayment of a term loan and existing bonds totaling $350 million and an additional $50 million tranche for future growth investments.
Powered by Capital Market – Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
First published: Thursday, July 14, 2022. 10:30 a.m. IST